AUSTIN SHANDLEY: Open Payments
NPI 1881085066 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,238 in 113 payments from 19 companies in 2025. Trend: 2023 $2,416 · 2024 $2,284 · 2025 $3,238
Food & beverage: $2,993Education: $210Travel & lodging: $36
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 19 | $554 |
| Janssen Biotech, Inc. | 13 | $498 |
| GENZYME CORPORATION | 7 | $396 |
| ABBVIE INC. | 18 | $313 |
| Lilly USA, LLC | 10 | $265 |
| Novartis Pharmaceuticals Corporation | 7 | $260 |
| Galderma Laboratories, L.P. | 6 | $197 |
| LEO Pharma Inc. | 3 | $186 |
| Incyte Corporation | 6 | $129 |
| Regeneron Healthcare Solutions, Inc. | 4 | $107 |
Products named: Bimzelx, TREMFYA, DUPIXENT, SKYRIZI, NEMLUVIO, Rhapsido, OPZELURA, COSENTYX.
Industry payments across MO — which companies pay providers there.
